ANGIOGENEX
AngioGenex is a biopharmaceutical company using unique anti-Id (Inhibitor of differentiation) technology initially incubated at Memorial Sloan Kettering Cancer Center, NYC.
ANGIOGENEX
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
1999-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.angiogenex.com
Total Employee:
1+
Status:
Active
Contact:
(347) 468-6799
Email Addresses:
[email protected]
Total Funding:
875 K USD
Technology used in webpage:
Euro Google Google Cloud Google Apps For Business Google DNS Google Domains Google Cloud DNS Wufoo Google Cloud Oregon
Similar Organizations
Acologix
Acologix is a biopharmaceutical company developing therapeutic compounds for the treatment of osteo-renal diseases.
Biohelix
Biohelix is to improve the quality of healthcare through the development of simple molecular diagnostic tests.
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
NanoBiotech Pharma
NanoBiotech Pharma, Inc is a healthcare company that focuses & deals with the treatment of cardiovascular diseases occurring in aged people.
Oncovir
Oncovir is a pharmaceutical company dedicated to the development of nucleic-acid-based clinical therapies.
Current Employees Featured
Stock Details
Investors List
Sand Hill Angels
Sand Hill Angels investment in Venture Round - AngioGenex
Atypical BioVentures
Atypical BioVentures investment in Venture Round - AngioGenex
Official Site Inspections
http://www.angiogenex.com
- Host name: 36.5.198.104.bc.googleusercontent.com
- IP address: 104.198.5.36
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "AngioGenex"
AngioGenex - Crunchbase Company Profile & Funding
Organization. AngioGenex . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... AngioGenex is a …See details»
AngioGenex Company Profile | Management and Employees List
AngioGenex and its collaborators, including Robert Benezra, Ph.D., and The Robert Benezra Lab at Sloan Kettering Institute, have assembled key platform enabling technologies and tools that …See details»
Angiogenex Company Profile 2024: Valuation, Funding …
Angiogenex General Information Description. Operator of a biopharmaceutical company intended to discover and develop ID protein inhibitors to address unmet medical needs in oncology and ophthalmology. The company offers …See details»
Angiogenex Inc (AGGX) Profile - The Globe and Mail
See the company profile for Angiogenex Inc (AGGX) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
AngioGenex Inc Overview - Salary.com
The trusted data and intuitive software your organization needs to get pay right. ... AngioGenex (Ticker: AGGX) is a biopharmaceutical company committed to the discovery and development …See details»
AngioGenex - Overview, News & Similar companies | ZoomInfo.com
Dec 5, 2017 Who is AngioGenex. AngioGenex (Ticker: AGGX) is a biopharmaceutical company committed to the discovery and development of Id protein inhibitors to address unmet medic al …See details»
Angiogenex Inc - LinkedIn
AngioGenex is a biopharmaceutical company committed to the discovery and development of Id protein inhibitors to address unmet medical needs in oncology and ophthalmology. …See details»
Angiogenex Company Profile -Sales, Contacts, Competitors - Buzzfile
Angiogenex is located in New York, New York. This organization primarily operates in the Pharmaceutical Preparations business / industry within the Chemicals and Allied Products …See details»
Angiogenex Inc Overview | SignalHire Company Profile
Angiogenex Inc is a public company that has been in the industry for 24 years. The company currently specializes in the Biotechnology area. ... Organization Website: angiogenex.com : …See details»
AngioGenex - Funding, Financials, Valuation & Investors
AngioGenex is a biopharmaceutical company dedicated to the development of treatment for vascular diseases. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ...See details»
AngioGenex - Products, Competitors, Financials, Employees, …
AngioGenex (Ticker: AGGX) is a biopharmaceutical company committed to the discovery and development of Id protein inhibitors to address unmet medical needs in oncology and …See details»
AngioGenex, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore AngioGenex, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Neoplasms, Technology Platform:Small molecule ...See details»
Angiogenex, Inc. Company Profile | New York, NY | Competitors ...
Angiogenex, Inc. Website. Get a D&B Hoovers Free Trial. Overview. Company Description:? Key Principal: Michael Aronstein See more contacts Industry: Pharmaceutical preparations. Printer …See details»
Company AngioGenex, Inc. - MarketScreener.com
AngioGenex, Inc. is a United States-based biopharmaceutical company, which is engaged in discovering and development of Id protein inhibitors to address unmet medical needs in …See details»
AngioGenex - Contacts, Employees, Board Members, Advisors
AngioGenex has 1 current employee profile, President, Chief Executive Officer and Board Member Edmon Jennings. Edmon Jennings President, Chief Executive Officer and Board …See details»
AngioGenex - Company Profile - Tracxn
Oct 20, 2024 Top competitors of AngioGenex include Unity Biotechnology, Alentis Therapeutics and American Gene. AngioGenex ranks 22 nd among 29 active competitors . 15 of its …See details»
AngioGenex's Leadership Team - Team members and org chart
AngioGenex's Leadership Team includes Robert Benezra and 3 others. Team members. Martin Murray. CFO & Director. Michael Aronstein. Chairman, President & CEO. Michael Strage. …See details»
AngioGenex, Inc. Stock (AGGX) - Quote OTC Markets
Feb 22, 2015 AngioGenex, Inc. is a United States-based biopharmaceutical company, which is engaged in discovering and development of Id protein inhibitors to address unmet medical …See details»
AngioGenex Merges With eClic, Inc., To Become A Public Company
NEW YORK, Feb. 1 /PRNewswire/ -- AngioGenex, Inc. a private biopharmaceutical company based in New York, New York, announced that it has merged with eClic, Inc., a reporting …See details»